OBJECTIVE: To describe the clinical course of attention-deficit/hyperactivity disorder (ADHD) symptom severity and diagnosis from ages 3 to 5 up to 9 to 12 years during a 6-year follow-up after the original Preschool ADHD Treatment Study (PATS). METHOD: A total of 207 participants (75% male) from the original PATS, assessed at baseline (mean age, 4.4 years, when all met criteria for ADHD) and 3 months later (before medication treatment), were re-evaluated in three follow-up assessment visits (year 3, mean age 7.4 years; year 4, 8.3 years; and year 6, 10.4 years). Parents and teachers rated symptom severity, and clinicians established psychiatric diagnoses. Analyses examined longitudinal changes in symptom severity and ADHD diagnosis. RESULTS: Parent- and teacher-rated symptom severity decreased from baseline to year 3 but remained relatively stable and in the moderate-to-severe clinical range through year 6. Girls showed generally steeper decreases in symptom T-scores. At year 6, 89% (160/180) of remaining participants met ADHD symptom and impairment diagnostic criteria. Comorbidity of oppositional defiant disorder and/or conduct disorder was associated with a 30% higher risk of having an ADHD diagnosis at year 6 in the multiple logistic model. Medication status during follow-up, on versus off, did not predict symptom severity change from year 3 to year 6 after adjustment for other variables. CONCLUSIONS: ADHD in preschoolers is a relatively stable diagnosis over a 6-year period. The course is generally chronic, with high symptom severity and impairment, in very young children with moderate-to-severe ADHD, despite treatment with medication. Development of more effective ADHD intervention strategies is needed for this age group.
OBJECTIVE: To describe the clinical course of attention-deficit/hyperactivity disorder (ADHD) symptom severity and diagnosis from ages 3 to 5 up to 9 to 12 years during a 6-year follow-up after the original Preschool ADHD Treatment Study (PATS). METHOD: A total of 207 participants (75% male) from the original PATS, assessed at baseline (mean age, 4.4 years, when all met criteria for ADHD) and 3 months later (before medication treatment), were re-evaluated in three follow-up assessment visits (year 3, mean age 7.4 years; year 4, 8.3 years; and year 6, 10.4 years). Parents and teachers rated symptom severity, and clinicians established psychiatric diagnoses. Analyses examined longitudinal changes in symptom severity and ADHD diagnosis. RESULTS: Parent- and teacher-rated symptom severity decreased from baseline to year 3 but remained relatively stable and in the moderate-to-severe clinical range through year 6. Girls showed generally steeper decreases in symptom T-scores. At year 6, 89% (160/180) of remaining participants met ADHD symptom and impairment diagnostic criteria. Comorbidity of oppositional defiant disorder and/or conduct disorder was associated with a 30% higher risk of having an ADHD diagnosis at year 6 in the multiple logistic model. Medication status during follow-up, on versus off, did not predict symptom severity change from year 3 to year 6 after adjustment for other variables. CONCLUSIONS:ADHD in preschoolers is a relatively stable diagnosis over a 6-year period. The course is generally chronic, with high symptom severity and impairment, in very young children with moderate-to-severe ADHD, despite treatment with medication. Development of more effective ADHD intervention strategies is needed for this age group.
Authors: Benjamin B Lahey; William E Pelham; Jan Loney; Heidi Kipp; Ashley Ehrhardt; Steve S Lee; Erik G Willcutt; Cynthia M Hartung; Andrea Chronis; Greta Massetti Journal: Am J Psychiatry Date: 2004-11 Impact factor: 18.112
Authors: Rex Forehand; Justin Parent; Edmund Sonuga-Barke; Virginia D Peisch; Nicholas Long; Howard B Abikoff Journal: J Abnorm Child Psychol Date: 2016-11
Authors: Rex Forehand; Justin Parent; Virginia D Peisch; Edmund Sonuga-Barke; Nicholas Long; Nicole Lafko Breslend; Howard B Abikoff Journal: Behav Res Ther Date: 2017-08-04
Authors: Deborah A Pearson; Cynthia W Santos; Michael G Aman; L Eugene Arnold; David M Lane; Katherine A Loveland; Rosleen Mansour; Anthony R Ward; Charles D Casat; Susan Jerger; Russell J Schachar; Oscar G Bukstein; Lynne A Cleveland Journal: J Child Adolesc Psychopharmacol Date: 2020-07-09 Impact factor: 2.576
Authors: Melissa L Danielson; Susanna N Visser; Mary Margaret Gleason; Georgina Peacock; Angelika H Claussen; Stephen J Blumberg Journal: J Dev Behav Pediatr Date: 2017-09 Impact factor: 2.225
Authors: Alexander G Fiks; Michelle E Ross; Stephanie L Mayne; Lihai Song; Weiwei Liu; Jennifer Steffes; Banita McCarn; Robert W Grundmeier; A Russell Localio; Richard Wasserman Journal: Pediatrics Date: 2016-11-15 Impact factor: 7.124
Authors: Howard B Abikoff; Margaret Thompson; Cathy Laver-Bradbury; Nicholas Long; Rex L Forehand; Laurie Miller Brotman; Rachel G Klein; Philip Reiss; Lan Huo; Edmund Sonuga-Barke Journal: J Child Psychol Psychiatry Date: 2014-10-16 Impact factor: 8.982
Authors: Patricia A Sirois; Lisa Aaron; Grace Montepiedra; Deborah A Pearson; Suad Kapetanovic; Paige L Williams; Patricia A Garvie; Molly L Nozyce; Kathleen Malee; Sharon L Nichols; Betsy L Kammerer; Wendy G Mitchell; Mark Mintz; James M Oleske Journal: Pediatr Infect Dis J Date: 2016-01 Impact factor: 2.129